Article
Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patients.
Oncotarget - 16 Aug 2016
Hsu Kuo-Hsuan, Tseng Jeng-Sen, Wang Chih-Liang, Yang Tsung-Ying, Tseng Chien-Hua, Chen Hsuan-Yu, Chen Kun-Chieh, Tsai Chi-Ren, Yang Cheng-Ta, Yu Sung-Liang, Su Kang-Yi, Yu Chong-Jen, Ho Chao-Chi, Hsia Te-Chun, Wu Ming-Fang, Chiu Kuo-Liang, Liu Chien-Ming, Yang Pan-Chyr, Chen Jeremy J W, Chang Gee-Chen
Abstract excerpt
Despite the advancement of epidermal growth factor receptor (EGFR) inhibitors in lung cancer therapy, it remains unclear whether EGFR mutation status in familial lung cancers is different from that of sporadic cases. In this multicenter retrospective study, we compared both the EGFR mutation frequency and patterns between familial and sporadic cases. The results explored that family history of lung cancer is an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
